Blood Loss, Postoperative
19
3
3
13
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.3%
1 terminated out of 19 trials
92.9%
+6.4% vs benchmark
16%
3 trials in Phase 3/4
23%
3 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (19)
Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony
IV Ketorolac on Platelet Function Post-Cesarean Delivery
Safe and Timely Antithrombotic Removal (STAR) Registry
Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)
Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T)
EFFICACY of INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION on the POSTOPERATIVE BLOOD LOSS in PATIENTS UNDERGOING RARP for the TREATMENT of PROSTATE CANCER
Estimated Blood Loss: Novel Model for Estimating Surgical Blood Loss.
Comparative Study Between Preoperative and Postoperative Rectal Misoprostol
Comparing Tranexamic Acid Versus Ecbolics in Preventing Hemorrhage During and After Cesarean Section
Perioperative Blood Transfusion in Open Liver Resection
Comparison Study of Oxytocin Versus Tranexamic Acid and Etamsylaye Versus Placebo(Saline)
Prospective Effect of Intravenous Ketorolac on Opioid Use, EBL and Complications Following Cesarean Delivery
Blood Loss Quantification During Major Abdominal Surgery
Comparative Study Between Oxytocin Versus Tranexamic Acid and Ethamsylate
Application of Iced Normal Saline Combined With Cocktail Perfusion in Total Knee Arthroplasty
Individualized Multimodal Hemostasis Evaluation Pyramid (IMHOTEP)
Fibrin Clot Properties and Blood Loss Following Coronary Artery By-pass Grafting
The Comparison of the Effect of Different Oxytocin Administrations on the Blood Loss During Cesarean Delivery
Non-inferiority Trial of Oral Tranexamic Acid vs. Intravenous Tranexamic Acid in Joint Replacement Surgery